rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2011-1-3
|
pubmed:abstractText |
A low level of intact parathyroid hormone (PTH) is an indicator of adynamic bone disease in hemodialysis patients, and is associated with a significant increase of all-cause mortality. Thus, effective treatment for adynamic bone disease is required. We previously investigated the effect of vitamin K? on adynamic bone disease. In this study, we assessed the efficacy of oral vitamin K? in a controlled trial.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1660-2110
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2010 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
c15-9
|
pubmed:meshHeading |
pubmed-meshheading:20689320-Aged,
pubmed-meshheading:20689320-Alkaline Phosphatase,
pubmed-meshheading:20689320-Biological Markers,
pubmed-meshheading:20689320-Bone Diseases,
pubmed-meshheading:20689320-Bone Remodeling,
pubmed-meshheading:20689320-Collagen Type I,
pubmed-meshheading:20689320-Female,
pubmed-meshheading:20689320-Humans,
pubmed-meshheading:20689320-Male,
pubmed-meshheading:20689320-Middle Aged,
pubmed-meshheading:20689320-Osteocalcin,
pubmed-meshheading:20689320-Parathyroid Hormone,
pubmed-meshheading:20689320-Peptides,
pubmed-meshheading:20689320-Renal Dialysis,
pubmed-meshheading:20689320-Statistics, Nonparametric,
pubmed-meshheading:20689320-Vitamin K 2
|
pubmed:year |
2011
|
pubmed:articleTitle |
Vitamin K? alters bone metabolism markers in hemodialysis patients with a low serum parathyroid hormone level.
|
pubmed:affiliation |
Department of Advanced Nephrology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|